Stem cells in bone diseases: current clinical practice
- PMID: 21813557
- DOI: 10.1093/bmb/ldr035
Stem cells in bone diseases: current clinical practice
Abstract
Introduction: Bone is an obvious candidate tissue for stem cell therapy. This review provides an update of existing stem cell-based clinical treatments for bone pathologies.
Sources of data: A systematic computerized literature search was conducted. The following databases were accessed on 10 February 2011: NIH clinical trials database, PubMed, Ovid and Cochrane Reviews.
Areas of agreement: Stem cell therapy offers new options for bone conditions, both acquired and inherited.
Areas of controversy: There is still no agreement on the exact definition of 'mesenchymal stem cells'. Consequently, it is difficult to appreciate the effect of culture expansion and the feasibility of allogeneic transplantation.
Growing points: Based on the sound foundations of pre-clinical research, stem cell-based treatments and protocols have recently emerged.
Areas timely for developing research: Well-designed prospective clinical trials are needed in order to establish and develop stem cell therapy for bone diseases.
Similar articles
-
Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.Foot Ankle Clin. 2005 Dec;10(4):651-65, viii. doi: 10.1016/j.fcl.2005.06.004. Foot Ankle Clin. 2005. PMID: 16297825 Review.
-
Mesenchymal stem cells and bone regeneration: current status.Injury. 2011 Jun;42(6):562-8. doi: 10.1016/j.injury.2011.03.030. Epub 2011 Apr 13. Injury. 2011. PMID: 21489533 Review.
-
Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair.Expert Opin Biol Ther. 2008 Mar;8(3):255-68. doi: 10.1517/14712598.8.3.255. Expert Opin Biol Ther. 2008. PMID: 18294098 Review.
-
Stem cell therapy for articular cartilage defects.Br Med Bull. 2011;99:227-40. doi: 10.1093/bmb/ldr032. Epub 2011 Aug 5. Br Med Bull. 2011. PMID: 21821628 Review.
-
Growing bone and cartilage. The role of mesenchymal stem cells.J Bone Joint Surg Br. 2006 Apr;88(4):421-6. doi: 10.1302/0301-620X.88B4.17060. J Bone Joint Surg Br. 2006. PMID: 16567773 Review. No abstract available.
Cited by
-
Interferon gamma and T cells inhibit osteogenesis induced by allogeneic mesenchymal stromal cells.J Orthop Res. 2013 Feb;31(2):227-34. doi: 10.1002/jor.22212. Epub 2012 Aug 10. J Orthop Res. 2013. PMID: 22886855 Free PMC article.
-
Suitability and limitations of mesenchymal stem cells to elucidate human bone illness.World J Stem Cells. 2019 Sep 26;11(9):578-593. doi: 10.4252/wjsc.v11.i9.578. World J Stem Cells. 2019. PMID: 31616536 Free PMC article. Review.
-
MESENCHYMAL STROMAL CELLS AND THEIR ORTHOPAEDIC APPLICATIONS.Case Orthop J. 2012;9(1):60-65. Case Orthop J. 2012. PMID: 26807425 Free PMC article. No abstract available.
-
The marine sponge-derived inorganic polymers, biosilica and polyphosphate, as morphogenetically active matrices/scaffolds for the differentiation of human multipotent stromal cells: potential application in 3D printing and distraction osteogenesis.Mar Drugs. 2014 Feb 21;12(2):1131-47. doi: 10.3390/md12021131. Mar Drugs. 2014. PMID: 24566262 Free PMC article.
-
Lentivirus transduced interleukin-1 receptor antagonist gene expression in murine bone marrow-derived mesenchymal stem cells in vitro.Mol Med Rep. 2015 Sep;12(3):4063-4070. doi: 10.3892/mmr.2015.4003. Epub 2015 Jun 26. Mol Med Rep. 2015. PMID: 26130370 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials